Newsroom
Category
January 29, 2020
Ruben A. Mesa, M.D., director of Mays Cancer Center at the newly named UT Health San Antonio MD Anderson Cancer Center, discusses the approval of fedratinib (Inrebic) in myelofibrosis and other JAK inhibitors in the treatment pipeline. Read the full story at OncLive
January 28, 2020
Ruben Mesa discusses the current state of the treatment landscape for patients with myeloproliferative neoplasms (MPNs).
January 27, 2020
Ruben Mesa, MD, director of Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, discusses the impact myelofibrosis has on patients’ quality of life while at the American Society of Hematology conference.
January 27, 2020
UT Health San Antonio has launched an intensive out-patient program for veterans suffering from post-traumatic stress disorder following the devastation caused by Hurricane Harvey.
January 24, 2020
Dr. Robyn Scherber,created an assessment form to help patients with myeloproliferative neoplasms explain their symptoms to their care team.
January 23, 2020
UT Health San Antonio and The University of Texas at San Antonio (UTSA) are starting a fast-track degree program for future respiratory therapists, a job that’s increasingly in demand.